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A 66-year-old man presented to the emergency department
with weakness and back pain. Remarkable laboratory results
included a hemoglobin of 6.1 g/dL (13.5–17.5 g/dL) and creatinine
of 17.3 mg/dL (0.6–1.3 mg/dL). Serum protein electrophoresis
showed a gamma paraprotein spike demonstrated by immuno-
ﬁxation to be IgG lambda. Serum free lambda light chains were
markedly elevated at 11,160 mg/L (5.7–26.3 mg/L). Bone marrow
biopsy demonstrated 80% plasma cells with lambda light chain
restriction, conﬁrming the diagnosis of plasma cell myeloma
(Fig. 1). Strikingly, both bone marrow (panel A) and renal (panel
B) biopsies showed numerous, extracellular, eosinophilic, rectan-
gular crystals measuring as large as several cell diameters and
staining positive for lambda light chains (panel C) and negative
for kappa light chains (panel D). Extracellular crystals have rarely
been reported in plasma cell myeloma, and to our knowledge,
only once previously demonstrated in both renal and bone
marrow tissue from the same patient [1]. The precise etiology of
these crystals is unknown; however, they are thought to arise
from the precipitation of light chains in certain cases. Our patient
received plasmapheresis and hemodialysis, followed by a
combination of steroids and bortezomib. Unfortunately, his
disease progressed rapidly despite treatment, resulting in
death from disease-related complications seven months after
diagnosis.
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